AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IRBESARTAN + AMLODIPINE
34 registrations across 4 African markets— 10 active
Markets with IRBESARTAN + AMLODIPINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| APROFORT 300MG/10MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | TERIAK JEBEL EL OUST | expired | Jan 2026 |
| APROFORT 300MG/5MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | TERIAK JEBEL EL OUST | expired | Jan 2026 |
| APROFORT 150MG/5MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | TERIAK JEBEL EL OUST | expired | Jan 2026 |
| ARAVEN IC Comprimé pelliculé / 150 mg/5 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Jun 2021 |
| ARAVEN IC Comprimé pelliculé / 150 mg/5 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Mar 2021 |
| ARAVEN IC Comprimé pelliculé / 300 mg/10 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2021 |
| ARAVEN IC Comprimé pelliculé / 300 mg/5 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2021 |
| APROFORT Comprimé pelliculé / 300 MG/10 MG | 🇹🇳Tunisia | TERIAK | expired | Jun 2020 |
| APROFORT Comprimé pelliculé / 300 MG/ 5MG | 🇹🇳Tunisia | TERIAK | expired | Jun 2020 |
| APROFORT Comprimé pelliculé / 150 MG/5 MG | 🇹🇳Tunisia | TERIAK | expired | Jun 2020 |
| ARADEUX PLUS 300/5 Comprimé pelliculé / 300 mg/5 mg | 🇹🇳Tunisia | SAIPH | expired | Nov 2019 |
| ARADEUX PLUS 150/5 Comprimé pelliculé / 150 mg/5 mg | 🇹🇳Tunisia | SAIPH | expired | Nov 2019 |
| ARADEUX PLUS 300/10 Comprimé pelliculé / 300 mg/10 mg | 🇹🇳Tunisia | SAIPH | expired | Nov 2019 |
| ARADEUX PLUS 300/5 Comprimé pelliculé / 300 mg/5 mg | 🇹🇳Tunisia | SAIPH | expired | Nov 2019 |
| ARADEUX PLUS Comprimé pelliculé / 300 mg/10 mg | 🇹🇳Tunisia | SAIPH | expired | Nov 2019 |
| ARADEUX PLUS 150/5 Comprimé pelliculé / 150 mg/5 mg | 🇹🇳Tunisia | SAIPH | expired | Nov 2019 |
| ARAVEN IC Comprimé pelliculé / 300 mg/5 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2019 |
| ARAVEN IC Comprimé pelliculé / 300 mg/10 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Feb 2019 |
| APROFORT Comprimé pelliculé / 300 mg/10mg | 🇹🇳Tunisia | TERIAK | expired | Oct 2018 |
| APROFORT Comprimé pelliculé / 150 mg/5 mg | 🇹🇳Tunisia | TERIAK | expired | Oct 2018 |
| APROFORT Comprimé pelliculé / 300 mg/5 mg | 🇹🇳Tunisia | TERIAK | expired | Oct 2018 |
| APROVASC Comprimé pelliculé / 150 mg/5 mg | 🇹🇳Tunisia | SANOFI AVENTIS PHARMA TUNISIE | expired | Sept 2014 |
| APROVASC Comprimé pelliculé / 300 mg/5 mg | 🇹🇳Tunisia | SANOFI AVENTIS PHARMA TUNISIE | expired | Sept 2014 |
| APROVASC Comprimé pelliculé / 300 mg/10mg | 🇹🇳Tunisia | SANOFI AVENTIS PHARMA TUNISIE | expired | Sept 2014 |
| APROVASC COMPRIMES / 150MG/5MG | 🇸🇳Senegal | SANOFI | active | — |
| APROVASC ® 150MG/5MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC ® 300MG/5MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC ® 300MG/10MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC ® 150MG/10MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC ® 150MG/5MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC ® 300MG/10MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC ® 300MG/5MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC ® 150MG/10MG CP BT(4x7) SANOFI AVENTIS 4x7 comprimés | 🇲🇬Madagascar | SANOFI AVENTIS MEXICO S.A | active | — |
| APROVASC COMPRIMES / 150MG/5MG | 🇸🇳Senegal | SANOFI | active | — |
IRBESARTAN + AMLODIPINE in Africa — Regulatory Overview
IRBESARTAN + AMLODIPINE is registered across 4 African markets with 34 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Madagascar, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 34 registrations, 10 (29%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.